Correlation Between Regeneron Pharmaceuticals and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Vertex Pharmaceuticals.
Diversification Opportunities for Regeneron Pharmaceuticals and Vertex Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Regeneron and Vertex is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Vertex Pharmaceuticals
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 30.57 times less return on investment than Vertex Pharmaceuticals. But when comparing it to its historical volatility, Regeneron Pharmaceuticals is 1.08 times less risky than Vertex Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 29,248 in Vertex Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of 18,868 from holding Vertex Pharmaceuticals or generate 64.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regeneron Pharmaceuticals vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Regeneron Pharmaceuticals |
| Vertex Pharmaceuticals |
Regeneron Pharmaceuticals and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regeneron Pharmaceuticals and Vertex Pharmaceuticals
The main advantage of trading using opposite Regeneron Pharmaceuticals and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |